Old Web
English
Sign In
Acemap
>
Paper
>
P42 Use of trametinib, a MEK1 inhibitor, to treat Erdheim Chester disease (ECD)
P42 Use of trametinib, a MEK1 inhibitor, to treat Erdheim Chester disease (ECD)
2020
Hoda Alkoky
Talha Munir
Frances A. Borg
Keywords:
Dermatology
Trametinib
Erdheim–Chester disease
Human leukocyte interferon
Disease remission
Medicine
Small blood vessel
Testicular mass
carotid arteries
Physical therapy
Myeloproliferative disease
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]